We represented a national pharmaceutical ingredient supplier and its wholly owned subsidiaries in a Department of Justice investigation involving allegations of False Claims Act violations related to inflated Average Wholesale Prices, kickbacks to physicians, and waivers of co-pay obligations. Following a multi-year investigation arising from four separate qui tam actions, we negotiated a successful resolution of the matter that was substantially less than the government’s alleged damages.
Representation of National Pharmaceutical Ingredient Supplier: U.S. ex rel. Hueseman v. PSI (W.D. Tex.); U.S. ex rel. Sten v. Midwest Compounders (N.D. Iowa)
Representation of National Pharmaceutical Ingredient Supplier: U.S. ex rel. Hueseman v. PSI (W.D. Tex.); U.S. ex rel. Sten v. Midwest Compounders (N.D. Iowa)
We represented a national pharmaceutical ingredient supplier and its wholly owned subsidiaries in a Department of Justice investigation involving allegations of False Claims Act violations related to inflated Average Wholesale Prices, kickbacks to physicians, and waivers of co-pay obligations. Following a multi-year investigation arising from four separate qui tam actions, we negotiated a successful resolution of the matter that was substantially less than the government’s alleged damages.